SMO ClinPlus Co. Ltd. (SHE:301257) — Market Cap & Net Worth
Market Cap & Net Worth: SMO ClinPlus Co. Ltd. (301257)
SMO ClinPlus Co. Ltd. (SHE:301257) has a market capitalization of $444.52 Million (CN¥3.04 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #12948 globally and #3819 in its home market, demonstrating a -1.28% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SMO ClinPlus Co. Ltd.'s stock price CN¥38.45 by its total outstanding shares 79004770 (79.00 Million). Also see SMO ClinPlus Co. Ltd. assets under control for a full breakdown of the balance sheet.
SMO ClinPlus Co. Ltd. Market Cap History: 2022 to 2026
SMO ClinPlus Co. Ltd.'s market capitalization history from 2022 to 2026. Data shows change from $421.14 Million to $444.52 Million (-8.58% CAGR). Also see cash flow conversion of SMO ClinPlus Co. Ltd. for how efficiently the company converts equity into cash flow.
SMO ClinPlus Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SMO ClinPlus Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 301257 stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.71x
SMO ClinPlus Co. Ltd.'s market cap is 0.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.49x
SMO ClinPlus Co. Ltd.'s market cap is 5.49 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $421.14 Million | $586.23 Million | $72.41 Million | 0.72x | 5.82x |
| 2023 | $559.65 Million | $760.04 Million | $134.73 Million | 0.74x | 4.15x |
| 2024 | $311.68 Million | $803.73 Million | $106.43 Million | 0.39x | 2.93x |
| 2025 | $601.63 Million | $842.50 Million | $109.64 Million | 0.71x | 5.49x |
Competitor Companies of 301257 by Market Capitalization
Companies near SMO ClinPlus Co. Ltd. in the global market cap rankings as of September 19, 2026. Review 301257 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to SMO ClinPlus Co. Ltd. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #89 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #160 globally with a market cap of $150.10 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #470 globally with a market cap of $58.08 Billion USD ( CN¥396.94 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #577 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #89 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $658.32 |
| #160 | Danaher Corporation | NYSE:DHR | $150.10 Billion | $212.50 |
| #470 | WuXi AppTec Co Ltd | SHG:603259 | $58.08 Billion | CN¥160.49 |
| #577 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $366.31 |
SMO ClinPlus Co. Ltd. Historical Marketcap From 2022 to 2026
Between 2022 and today, SMO ClinPlus Co. Ltd.'s market cap moved from $421.14 Million to $ 444.52 Million, with a yearly change of -8.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥444.52 Million | -26.11% |
| 2025 | CN¥601.63 Million | +93.03% |
| 2024 | CN¥311.68 Million | -44.31% |
| 2023 | CN¥559.65 Million | +32.89% |
| 2022 | CN¥421.14 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of SMO ClinPlus Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $444.52 Million USD |
| MoneyControl | $444.52 Million USD |
| MarketWatch | $444.52 Million USD |
| marketcap.company | $444.52 Million USD |
| Reuters | $444.52 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SMO ClinPlus Co. Ltd.
SMO ClinPlus CO.,LTD. provides site management services in research and development in pharmaceuticals, medical devices, and health-related products in China. It offers clinical trial site management organization services to pharmaceuticals, medical devices, CRO companies, etc. The company offers preliminary modeling and preparation plans, trial site initiation, on-site execution, and project man… Read more